Drug intelligence / Profile preview

dipyrone + chlorpheniramine maleate + phenylephrine hydrochloride

Development stage
Phase 3
Lead developer
Brainfarma
Modality
Small Molecules
Administration
Oral
01

Overview

The combination of dipyrone (metamizole), chlorpheniramine maleate, and phenylephrine hydrochloride is a multi-ingredient pharmaceutical formulation used for the symptomatic relief of the common cold, influenza, and related upper respiratory tract infections. Primarily marketed in regions such as Brazil, this combination provides a triple therapeutic approach: **dipyrone** acts as a non-opioid analgesic and antipyretic by inhibiting prostaglandin synthesis; **chlorpheniramine maleate** is a first-generation antihistamine that reduces symptoms such as sneezing, rhinorrhea, and watery eyes by antagonizing histamine H1 receptors; and **phenylephrine hydrochloride** is a sympathomimetic decongestant that acts as an alpha-1 adrenergic receptor agonist to constrict blood vessels in the nasal passages, thereby reducing congestion. This specific triple combination is most commonly found in oral solution or liquid drops formulations, whereas capsule versions of similar brands often substitute dipyrone with paracetamol or acetylsalicylic acid.

Brand names
ResfenolMultigripCimegripeGriponia
Other names
metamizole + chlorpheniramine + phenylephrinedipirona + clorfeniramina + fenilefrinadipyrone + chlorphenamine + phenylephrine
02

Targets

ADRA1A (α1A)COXHRH1 (Histamine H1 Receptor)

Beyond the preview

Go deeper on dipyrone + chlorpheniramine maleate + phenylephrine hydrochloride.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on dipyrone + chlorpheniramine maleate + phenylephrine hydrochloride.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call